CJ Bioscience Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CJ Bioscience Inc

Watchlist Manager

Watchlist

Price: 3 695 KRW 0.14%

Market Cap: ₩48.3B

C	CJ Bioscience Inc KOSDAQ:311690	KR
D	Delfi Ltd OTC:PEFDF	SG
	Lincoln Electric Holdings Inc NASDAQ:LECO	US
R	Revvity Inc XMUN:PKN	US
C	CECONOMY AG F:CEC	DE

Profitability Summary

CJ Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

21%

Sustainable 3Y Average Gross Margin

19%

Declining Gross Margin

41% > 21%

Negative Operating Margin

-625%

Negative 3Y Average Operating Margin

-757%

Operating Margin is Increasing

-669% > -625%

Negative Net Margin

-607%

Negative 3Y Average Net Margin

-668%

Net Margin is Increasing

-655% > -607%

Negative Free Cash Flow Margin

-540%

Negative 3Y Average Free Cash Flow Margin

-709%

Free Cash Flow Margin is Increasing

-773% > -540%

Negative ROE

-42%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-112%

Declining ROIC

-83% > -132%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.